Yellow Fever Human Infection Model With YF-17D
Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
No antiviral treatment exists for yellow fever, only supportive care, and therefore we rely on prevention through vaccination. Although this vaccine is very effective, stockpiles are insufficient in outbreak situations and some people have a contraindication to be vaccinated. For those who are unprotected and at risk of yellow fever infection, treatment could be life saving.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:
• age 18-50 years
Locations
Other Locations
Netherlands
Leiden University Medical Center
RECRUITING
Leiden
Contact Information
Primary
Anna H Roukens, MD, PhD
a.h.e.roukens@lumc.nl
+31715262613
Backup
Leo G Visser, MD PhD
l.g.visser@lumc.nl
+31715262613
Time Frame
Start Date: 2023-02-17
Completion Date: 2024-03-01
Participants
Target number of participants: 30
Treatments
Other: intervention arm
yellow fever vaccine arm (all participants receive the standard yellow fever vaccine (Stamaril)
Related Therapeutic Areas
Sponsors
Collaborators: The International Society of Travel Medicine
Leads: Leiden University Medical Center